Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Platelet transfusion in neonatal intensive care units of 22 European countries : a prospective observational study
Authors:ID Houben, Nina A. M. (Author)
ID Lopriore, Enrico (Author)
ID Fijnvandraat, Karin (Author)
ID Caram-Deelder, Camila (Author)
ID Aguar Carrascosa, Marta (Author)
ID Beuchée, Alain (Author)
ID Brække, Kristin (Author)
ID Cardona, Francesco Stefano (Author)
ID Debeer, Anne (Author)
ID Domingues, Sara (Author)
ID Lozar Krivec, Jana (Author), et al.
Files:.pdf PDF - Presentation file, download (661,25 KB)
MD5: B7AC995FA60B11262DC656DC11AEA85E
 
URL URL - Source URL, visit https://www.thelancet.com/action/showPdf?pii=S2666-7762%2824%2900253-9
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Background: Platelet transfusions are given to preterm infants with severe thrombocytopenia aiming to prevent haemorrhage. The PlaNeT2/MATISSE trial revealed higher rates of mortality and/or major bleeding in preterm infants receiving prophylactic platelet transfusions at a platelet count threshold of 50 × 109/L compared to 25 × 109/L. The extent to which this evidence has been incorporated into clinical practice is unknown, thus we aimed to describe current neonatal platelet transfusion practices in Europe. Methods: We performed a prospective observational study in 64 neonatal intensive care units across 22 European countries between September 2022 and August 2023. Outcome measures included observed transfusion prevalence rates (per country and overall, pooled using a random effects Poisson model), expected rates based on patient-mix (per country, estimated using logistic regression), cumulative incidence of receiving a transfusion by day 28 (with death and discharge considered as competing events), transfusion indications, volumes and infusion rates, platelet count triggers and increment, and adverse effects. Findings: We included 1143 preterm infants, of whom 71 (6.2%, [71/1143]) collectively received 217 transfusions. Overall observed prevalence rate was 0.3 platelet transfusion days per 100 admission days. By day 28, 8.3% (95% CI: 5.5–11.1) of infants received a transfusion. Most transfusions were indicated for threshold (74.2%, [161/217]). Pre-transfusion platelet counts were above 25 × 109/L in 33.1% [53/160] of these transfusions. There was significant variability in volume and duration. Interpretation: The restrictive threshold of 25 × 109/L is being integrated into clinical practice. Research is needed to explore existing variation and generate evidence for various aspects including optimal volumes and infusion rates.
Keywords:platelet transfusion, thrombocytopenia, preterm infants, neonatology, neonatal intensive care unit, epidemiology
Publication status:Published
Publication version:Version of Record
Year of publishing:2024
Number of pages:str. 1-11
Numbering:Vol. 47, [article no.] ǂ101086
PID:20.500.12556/DiRROS-27872 New window
UDC:618.2/.7
ISSN on article:2666-7762
DOI:10.1016/j.lanepe.2024.101086 New window
COBISS.SI-ID:229912579 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 23. 3. 2025;
Publication date in DiRROS:26.02.2026
Views:142
Downloads:56
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:The Lancet regional health : Europe
Publisher:Elsevier Ltd.
ISSN:2666-7762
COBISS.SI-ID:56262915 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Back